Melatonin and COVID-19: May mean the difference between life and death
As of March 2024, there are more than 16 published clinical studies of melatonin for treatment and prevention in COVID-19 and the results are promising even when it's given as a late treatment. On the last day of 2021, Melatonin Research published a research commentary discussing an October 2021 study by Hasan et. al ., which found melatonin significantly lowered mortality when given to severely infected COVID patients. According to the authors: “In a single-center, open-label, randomized clinical trial, it was observed that melatonin treatment lowered the mortality rate by 93% in severely-infected COVID-19 patients compared with the control group. This is seemingly the first report to show such a huge mortality reduction in severe COVID-19 infected individuals with a simple treatment. If this observation is confirmed by more rigorous clinical trials, melatonin could become an important we...